Nano-X Imaging (NNOX) Competitors $4.67 -0.24 (-4.89%) Closing price 04:00 PM EasternExtended Trading$4.69 +0.02 (+0.43%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNOX vs. MDXG, FNA, BLFS, AORT, RXST, EYE, PLSE, AXGN, BVS, and EMBCShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include MiMedx Group (MDXG), Paragon 28 (FNA), BioLife Solutions (BLFS), Artivion (AORT), RxSight (RXST), National Vision (EYE), Pulse Biosciences (PLSE), AxoGen (AXGN), Bioventus (BVS), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. MiMedx Group Paragon 28 BioLife Solutions Artivion RxSight National Vision Pulse Biosciences AxoGen Bioventus Embecta Nano-X Imaging (NASDAQ:NNOX) and MiMedx Group (NASDAQ:MDXG) are both small-cap business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Do insiders and institutionals hold more shares of NNOX or MDXG? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 1.3% of MiMedx Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, NNOX or MDXG? Nano-X Imaging has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500. Does the MarketBeat Community favor NNOX or MDXG? MiMedx Group received 13 more outperform votes than Nano-X Imaging when rated by MarketBeat users. Likewise, 82.14% of users gave MiMedx Group an outperform vote while only 73.33% of users gave Nano-X Imaging an outperform vote. CompanyUnderperformOutperformNano-X ImagingOutperform Votes3373.33% Underperform Votes1226.67% MiMedx GroupOutperform Votes4682.14% Underperform Votes1017.86% Does the media prefer NNOX or MDXG? In the previous week, Nano-X Imaging had 21 more articles in the media than MiMedx Group. MarketBeat recorded 23 mentions for Nano-X Imaging and 2 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.15 beat Nano-X Imaging's score of -0.17 indicating that MiMedx Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 2 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral MiMedx Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate NNOX or MDXG? Nano-X Imaging currently has a consensus target price of $12.00, suggesting a potential upside of 153.16%. MiMedx Group has a consensus target price of $12.00, suggesting a potential upside of 63.27%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than MiMedx Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, NNOX or MDXG? MiMedx Group has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$10.68M25.64-$60.78M-$0.85-5.58MiMedx Group$348.88M3.10$58.23M$0.2826.25 Is NNOX or MDXG more profitable? MiMedx Group has a net margin of 23.86% compared to Nano-X Imaging's net margin of -465.38%. MiMedx Group's return on equity of 26.21% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-465.38% -27.63% -24.72% MiMedx Group 23.86%26.21%18.15% SummaryMiMedx Group beats Nano-X Imaging on 12 of the 17 factors compared between the two stocks. Remove Ads Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingX IndustryBusiness SectorNASDAQ ExchangeMarket Cap$273.87M$11.67B$7.01B$7.57BDividend YieldN/A1.87%2.53%4.04%P/E Ratio-5.5817.8529.3518.16Price / Sales25.647.70148.7886.29Price / CashN/A11.9031.4034.64Price / Book1.342.014.594.01Net Income-$60.78M$344.53M$192.88M$247.18M7 Day Performance-13.19%-8.46%-4.30%-5.86%1 Month Performance-16.99%-12.94%-4.18%-6.95%1 Year Performance-56.35%-6.72%0.52%-3.71% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging1.5664 of 5 stars$4.67-4.9%$12.00+157.0%-50.5%$269.83M$10.68M-5.49190Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageGap DownMDXGMiMedx Group3.095 of 5 stars$7.65+1.5%$12.00+56.9%+11.8%$1.12B$348.88M13.86870Positive NewsFNAParagon 281.4065 of 5 stars$13.07+0.2%$14.20+8.7%+11.9%$1.10B$256.18M-17.66343,000BLFSBioLife Solutions1.6554 of 5 stars$22.82-12.1%$29.86+30.9%+35.1%$1.07B$82.25M-21.45440Analyst DowngradePositive NewsAORTArtivion3.3367 of 5 stars$24.70+1.8%$31.40+27.1%+20.3%$1.04B$388.54M-1,231.251,300Positive NewsGap DownRXSTRxSight3.4171 of 5 stars$25.51-4.0%$49.33+93.4%-48.2%$1.03B$139.93M-30.68220Analyst ForecastNews CoverageGap DownEYENational Vision2.2228 of 5 stars$12.82flat$14.00+9.2%-38.5%$1.01B$1.82B-64.0514,000Short Interest ↑Positive NewsPLSEPulse Biosciences1.0901 of 5 stars$16.20-2.4%N/A+117.6%$993.01M$700,000.000.00140Analyst UpgradeGap DownAXGNAxoGen3.5025 of 5 stars$18.59+1.3%$22.60+21.6%+126.5%$823.25M$187.34M-58.02450Short Interest ↓Analyst RevisionBVSBioventus3.1705 of 5 stars$9.14+1.2%$15.00+64.1%+88.7%$747.66M$573.28M-14.961,200Positive NewsEMBCEmbecta4.7749 of 5 stars$12.78+4.1%$23.00+80.0%-1.6%$736.67M$1.11B12.671,900Short Interest ↓News CoveragePositive News Remove Ads Related Companies and Tools Related Companies MiMedx Group Competitors Paragon 28 Competitors BioLife Solutions Competitors Artivion Competitors RxSight Competitors National Vision Competitors Pulse Biosciences Competitors AxoGen Competitors Bioventus Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NNOX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
